Bluejay Diagnostics (BJDX) Cash from Operations (2020 - 2026)
Bluejay Diagnostics (BJDX) posted Cash from Operations of 1589200.0 for Q1 2026, down 9.23% sequentially from 1454870.0 in Q4 2025, and down 34.13% YoY from 2412480.42 in Q1 2025.
Bluejay Diagnostics (BJDX) Cash from Operations (2020 - 2026) Analysis & Trends
Bluejay Diagnostics has reported Cash from Operations for 7 years, with the latest figure at 1589200.0 in Q1 2026.
- Quarterly Cash from Operations fell 34.13% year-over-year to 1589200.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 6457918.0 (up 3.7% YoY) and the FY2025 annual result came in at 6053575.0, up 22.6% from the prior year.
- Cash from Operations retreated to 1589200.0 in Q1 2026 per BJDX's latest filing, from 1454870.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 1125066.0 in Q3 2023 and troughed at 2944243.0 in Q4 2022.
- A 5-year average of 1854062.35 and a median of 1659062.0 in 2022 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2022 and 2025: Cash from Operations plunged 403.8% in 2022, then soared 48.48% in 2025.
- Over 5 years, Cash from Operations stood at 2944243.0 in 2022, then grew by 5.66% to 2777477.0 in 2023, then jumped by 47.75% to 1451345.0 in 2024, then retreated by 0.24% to 1454870.0 in 2025, then decreased by 9.23% to 1589200.0 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 1589200.0, 1454870.0, and 1359793.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 2.49 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 1.26 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 2.57 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 651.90 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 269.20 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 168.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 437.05 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 367.10 Mn |
| 10 | Bluejay Diagnostics | 1.89 Mn | 1.89 Mn | - | -1.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.50 Mn |
| Jun 30, 2026 | -1.50 Mn |
| Mar 31, 2026 | -1.59 Mn |
| Mar 31, 2026 | -1.59 Mn |
| Dec 31, 2025 | -1.45 Mn |
| Dec 31, 2025 | -1.45 Mn |
| Sep 30, 2025 | -1.36 Mn |
| Sep 30, 2025 | -1.36 Mn |
| Jun 30, 2025 | -2.05 Mn |
| Jun 30, 2025 | -2.05 Mn |
| Mar 31, 2025 | -1.18 Mn |
| Mar 31, 2025 | -1.18 Mn |
| Dec 31, 2024 | -1.45 Mn |
| Dec 31, 2024 | -1.45 Mn |
| Sep 30, 2024 | -2.15 Mn |
| Sep 30, 2024 | -2.15 Mn |
| Jun 30, 2024 | -1.91 Mn |
| Jun 30, 2024 | -1.91 Mn |
| Mar 31, 2024 | -2.30 Mn |
| Mar 31, 2024 | -2.30 Mn |